Obesity Firm Kailera Therapeutics Up 63% After $625 Million IPO
Kailera Therapeutics Inc. shares surged 63% after the clinical-stage biotechnology company focused on obesity raised $625 million in an upsized US initial public offering.
Cerebras Systems Files for IPO
- Cerebras, an A.I. Chip Maker, Files to Go Public as Tech Offerings Ramp Up The New York Times —
- AI chipmaker Cerebras files for IPO following mega deal with OpenAI Seeking Alpha —
- AI chipmaker Cerebras set to file for IPO as soon as today CNBC —
- Nvidia rival Cerebras reveals US IPO filing as AI boom drives listings - Reuters Reuters —
- AI Chipmaker Cerebras Systems Files Publicly Again for US IPO Bloomberg —